Key result
Inhibition of lactate production ameliorated myocardial injury and shifted macrophage phenotype from a pro-inflammatory to an anti-inflammatory subtype by reducing H4K5 lactylation-mediated Rap1 transcription.
Why the study?
Acute myocarditis is a non-ischemic cardiomyopathy with high mortality where immunometabolic reprogramming of macrophages is key, but the underlying mechanisms remain to be clarified.
Does inhibition of lactate production improve cardiac function and reduce inflammation in murine models of acute myocarditis?
Does inhibition of lactate production improve cardiac function and reduce inflammation in murine models of acute myocarditis?
Inhibition of lactate production and H4K5 lactylation reduces macrophage-driven inflammation and improves cardiac function in murine models of acute myocarditis.
Does not support clinical use; hypothesis-generating for lactate inhibition in macrophage-driven myocarditis.
Acute myocarditis is a non-ischemic cardiomyopathy with rapid onset and high mortality. Immunometabolic reprogramming of macrophages is a key pathological feature. However the understanding of its mechanisms remains to be clarified. In this study, we found that acute myocarditis induced an increase in glycolysis and lactate accumulation. Inhibition of lactate production ameliorated myocardial injury. Further, we demonstrated that lactate promoted a pro-inflammatory transition of macrophages, thereby amplifying the inflammatory response. Inhibition of lactate in macrophage shifted its phenotype from a pro-inflammatory to an anti-inflammatory subtype. We also observed a significant increase in H4K5 lactylation in macrophages. Next, we identified that H4K5la drove the transcriptional expression of the Rap1, which in turn upregulated the TNF/NF-κB signaling. This lactate-dependent H4K5la was enriched in inflammatory pathways, forming a positive feedback loop that amplified inflammation. Inhibition of Rap1 reduced cardiac inflammation and broke this loop. These consequently lowered H4K5la levels and delayed ventricular remodeling. Collectively, this study reveals the role of H4K5la in promoting inflammatory cascades in myocarditis, and provides a potential therapeutic target for inflammatory cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied Acute myocarditis. LDHA inhibition (FX-11 or genetic knockout) vs. Vehicle/Control was evaluated on Myocardial injury and cardiac function (LVEF, LVFS). Inhibition of lactate production ameliorated myocardial injury and shifted macrophage phenotype from a pro-inflammatory to an anti-inflammatory subtype by reducing H4K5 lactylation-mediated Rap1 transcription.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: